Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $10.8 Million - $13.7 Million
-78,510 Closed
0 $0
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $4.94 Million - $6.13 Million
37,436 Added 91.14%
78,510 $12.7 Million
Q4 2021

Feb 01, 2022

BUY
$107.43 - $135.93 $104,959 - $132,803
977 Added 2.44%
41,074 $5.56 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $89,638 - $99,862
852 Added 2.17%
40,097 $4.52 Million
Q4 2020

Feb 08, 2021

BUY
$80.49 - $108.67 $2,897 - $3,912
36 Added 0.09%
39,245 $4.21 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $40,807 - $47,894
475 Added 1.23%
39,209 $3.43 Million
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $96,188 - $128,713
1,311 Added 3.5%
38,734 $3.8 Million
Q1 2020

May 08, 2020

BUY
$64.5 - $97.79 $34,443 - $52,219
534 Added 1.45%
37,423 $2.85 Million
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $23,586 - $29,511
327 Added 0.89%
36,889 $3.27 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $44,148 - $53,079
701 Added 1.95%
36,562 $2.77 Million
Q2 2019

Jul 30, 2019

BUY
$65.7 - $83.98 $42,967 - $54,922
654 Added 1.86%
35,861 $2.61 Million
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $180,816 - $212,811
2,344 Added 7.13%
35,207 $2.84 Million
Q4 2018

Feb 08, 2019

BUY
$77.85 - $96.01 $61,890 - $76,327
795 Added 2.48%
32,863 $3.03 Million
Q3 2018

Nov 07, 2018

BUY
$88.91 - $98.84 $46,944 - $52,187
528 Added 1.67%
32,068 $3.03 Million
Q2 2018

Aug 10, 2018

BUY
$89.78 - $106.23 $65,718 - $77,760
732 Added 2.38%
31,540 $2.92 Million
Q1 2018

May 04, 2018

BUY
$92.01 - $123.21 $51,893 - $69,490
564 Added 1.86%
30,808 $2.92 Million
Q4 2017

Feb 07, 2018

BUY
$89.56 - $98.21 $73,170 - $80,237
817 Added 2.78%
30,244 $2.93 Million
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $2.06 Million - $2.63 Million
29,427
29,427 $2.62 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Agf Investments America Inc. Portfolio

Follow Agf Investments America Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Agf Investments America Inc., based on Form 13F filings with the SEC.

News

Stay updated on Agf Investments America Inc. with notifications on news.